Peptide Sciences is gone. Dozens of sellers are next. The FDA is moving on compounded GLP-1s, and the loudest voices in this space sell the very things they review. Peptidiary is the independent read: vendor vetting, lab-test analysis, enforcement news, and real protocols. No hype. No scolding. Just what's actually happening.
Independent vendor and source vetting, so you're not guessing where the next batch comes from.
Lab and COA analysis. Roughly 42% of online peptide products test inaccurate. We tell you which.
The enforcement and shutdown beat. Raids, warning letters, FDA moves, the moment they land.
What people actually do, reported in context. Education, never a sales pitch and never medical advice.
The mainstream tells peptide users they're being conned. The influencers sell them injectables at a markup. Neither one serves the person who just wants honest, current information they can trust. That's the gap. Peptidiary is written for the reader, not for a storefront and not for a headline.